AstraZeneca's Alexion Pharmaceuticals acquisition open for feedback in EU
MLex Summary: Parties interested in AstraZeneca's planned acquisition of US rival Alexion Pharmaceuticals can now send their observations to the European Commission. The invitation to send input was published in the EU's...To view the full article, register now.
Already a subscriber? Click here to view full article